Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma

Figure 1

(a) Weak immunostaining for PSMA in PDAC tumor cells. ((b) and (c)) Strong PSMA expression in tumor-associated neovasculature. ((d)–(f)) Software-based assessment of microvessel density (MVD) in CD34-stained tissue microarrays. (g) Strong expression of PSMA in 22Rv1 prostate adenocarcinoma cells, but not in PDAC or HUVEC endothelial cell lines.

(a)

(b)

(c)

(d)

(e)

(f)

(g)